Personalized Medicines

Global Market Trajectory & Analytics

MCP-7877

EXECUTIVE ENGAGEMENTS

POOL

16256
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1626
Interactions with Platform & by Email

PARTICIPANTS

323
Unique # Participated

VALIDATIONS

81
Responses Validated*

COMPANIES

87
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

54

PAGES

171

EDITION

20

PRICE

USD 5450

CODE

MCP-7877


COMPETITIVE METRICS

COMPANY

D S N T

% *

1Datapoint Diagnostics

Login Required

20/20 Genesystems, Inc.

Login Required

2B BlackBio

Login Required

3D Medicines Corporation

Login Required

3D Signatures

Login Required

3G Biotech (China) Company

Login Required

4D Healthware

Login Required

Abbott Laboratories, Inc.

Login Required

Abbott Molecular, Inc.

Login Required

Abionic

Login Required

SUBMIT
* D = Dominant; S = Strong; N = Niche; T = Trivial
* Validated respondents are incentivized with cluster data
Note: Best viewed in Landscape Mode
VIEW ENTIRE POOL OF 87 COMPETITORS

Sign-in with email to View Deeper Validated Engagement Details -

  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Personalized Medicines estimated at US$227.9 Billion in the year 2020, is projected to reach a revised size of US$515.3 Billion by 2027, growing at aCAGR of 12.4% over the period 2020-2027. Tests & Lab Services, one of the segments analyzed in the report, is projected to record 11.3% CAGR and reach US$296.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Targeted Therapeutics segment is readjusted to a revised 13.9% CAGR for the next 7-year period.
The Personalized Medicines market in the U.S. is estimated at US$67.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$90.5 Billion by the year 2027 trailing a CAGR of 12% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.7% and 10.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.

SELECT PLAYERS

Abbott Molecular; Beckman Coulter, Inc.; bioMérieux SA; Bristol-Myers Squibb Company; Dako Denmark A/S; F. Hoffmann-La Roche Ltd.; GlaxoSmithKline Plc; Hologic, Inc.; Lab 21 Limited; Macrogen, Inc.; NeoGenomics Laboratories, Inc.; Novartis AG; QIAGEN NV; Rosetta Genomics Ltd.; Thermo Fischer Scientific Inc.

SEGMENTS

» Type (Tests & Lab Services, Targeted Therapeutics)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Access to Valuable Genetic Information Ushers Transformation in Medicine
Recent Market Activity
Market Outlook
Adoption of Personalized Medicines - A Peek into Developed and Developing Economies
Increasing Market Availability of Personalized Medicines
Select Key Approved Personalized Medicines and Associated Biomarkers by Therapeutic Area
Constraints in Traditional Approach to Treatment Creates Need and Demand for Personalized Medicine
Economics of Personalized Medicine
Is Emergence of Personalized Medicine Signaling the End of Blockbusters?
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
Abbott Molecular, Inc. (USA)
Beckman Coulter Genomics (USA)
bioMérieux SA (France)
Bristol-Myers Squibb Company (USA)
Dako Denmark A/S (Denmark)
F. Hoffmann-La Roche Ltd. (Switzerland)
GlaxoSmithKline plc. (UK)
Hologic, Inc. (USA)
Lab 21 Limited (UK)
Macrogen, Inc. (Korea)
NeoGenomics Laboratories, Inc. (USA)
Novartis AG (Switzerland)
QIAGEN NV (The Netherlands)
Rosetta Genomics Ltd (Israel)
Thermo Fisher Scientific Inc. (USA)
3. MARKET TRENDS & DRIVERS
Growth Drivers in a Gist
Key Market Restraints
Increasing Incidence and Prevalence of CDDs: A Major Growth Driver
Oncology - A Major Application Market
Diagnosed Cases of Cancer on the Rise
World Cancer Statistics: Incidence and Mortality Data
Growing Cancer Cases in Developing Countries Bodes Well for the Personalized Medicine Market
Growing Importance of Personalized Drugs for Cancer Treatment
Ballooning Global Population Offers Significant Growth Opportunities
Aging Global Population Drives Personalized Medicines
Increasing Healthcare Spending in Emerging Markets
Changing Patients' Trends Drive Personalized Medicine
Technological Advancements and Consumer Push to Drive Personalized Medicine
Minimizing Adverse Events - A Major Benefit of Personalized Medicines
Personalized Medicines Brings Disease Prevention Closer to Reality
Ability to Manage Healthcare Costs Piques Industry and Government Alike
Potential to Uncover Additional Prospective Targets - A Major Benefit in Pursuit
Elimination of Invasive Tests Attracts Patients and Doctors towards Molecular Test-based Personalized Medicines
Genomics to Dictate Advancement of Personalized Medicines
Companion Diagnostics Drive Personalized Medicine
Biomarkers as Companion Diagnostics
Personalized Medicines Help Reducing R&D Costs
Personalized Medicine - A Corporate Growth Strategy
Development Pipeline Reveals Promising Picture for Personalized Medicine
Advancements in Biomedical Imaging to Enhance Personalized Medicines
Increasing Use of Personalized Medicines Drives Genetic Testing
Genetic Testing: The Rapidly Growing Segment of Molecular Diagnostics Market
Next-Generation Sequencing - A Giant Leap in Genome Sequencing
Single Nucleotide Polymorphism (SNP) - Making Advancements in Personalized Medicine
Personalized Medicine Goes Beyond DNA Analysis
Combination Approaches May Mark Future Endeavors
Need for New Designs in Clinical Trials Emerges in Therapies for Rare Cancers
Immunotherapy for Cancers - A Potential Breakthrough in the Sector
Personalized Medicine Industry - Inundated with Data
Advanced Computing Technologies - The Need of The Hour to Analyze Large Data
Artificial Intelligence Revolutionizing Personalized Medicine
Challenges Aplenty for Precision Medicine
Lack of Clinically Useful Diagnostic Tests - Growth Dampener
Pricing and Value Dilemma Haunts Personalized Medicines
Bedside Biopharmaceutical Production to Dramatically Reduce Cost of Personalized Medicine
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Personalized Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Personalized Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Personalized Medicines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Tests & Lab Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Tests & Lab Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Tests & Lab Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Targeted Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Targeted Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Targeted Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Personalized Medicines by Type - Percentage Breakdown of Value Sales for Tests & Lab Services and Targeted Therapeutics for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Personalized Medicines by Type - Percentage Breakdown of Value Sales for Tests & Lab Services and Targeted Therapeutics for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Personalized Medicines by Type - Percentage Breakdown of Value Sales for Tests & Lab Services and Targeted Therapeutics for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Personalized Medicines by Type - Percentage Breakdown of Value Sales for Tests & Lab Services and Targeted Therapeutics for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Personalized Medicines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Personalized Medicines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Personalized Medicines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Personalized Medicines by Type - Percentage Breakdown of Value Sales for Tests & Lab Services and Targeted Therapeutics for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Personalized Medicines by Type - Percentage Breakdown of Value Sales for Tests & Lab Services and Targeted Therapeutics for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Personalized Medicines by Type - Percentage Breakdown of Value Sales for Tests & Lab Services and Targeted Therapeutics for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Personalized Medicines by Type - Percentage Breakdown of Value Sales for Tests & Lab Services and Targeted Therapeutics for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Personalized Medicines by Type - Percentage Breakdown of Value Sales for Tests & Lab Services and Targeted Therapeutics for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Personalized Medicines by Type - Percentage Breakdown of Value Sales for Tests & Lab Services and Targeted Therapeutics for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Personalized Medicines by Type - Percentage Breakdown of Value Sales for Tests & Lab Services and Targeted Therapeutics for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Personalized Medicines by Type - Tests & Lab Services and Targeted Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Personalized Medicines by Type - Percentage Breakdown of Value Sales for Tests & Lab Services and Targeted Therapeutics for the Years 2012, 2020 & 2027
Total Companies Profiled: 87

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com